Join our mailing list

ISSX European Meeting
Booth #304
June 22 – 25, 2015
Glasgow, Scotland

Japan SOT Annual Meeting
June 29 – July 1, 2015
Ishikawa, Japan


 Visit Eurofins Pharma Drug Discovery Services at ISSX 2015
REMINDER The deadline to submit cancer compounds for the July OncoPanel™ run is July 13!
    In vivo preclinical safety and efficacy
The largest selection of target-based binding and functional assays for assessing compound potency & selectivity

  A systems based approach to screen for compound potency & liability as well as related predictive biomarkers using human cell models of oncology, immunology and cellular toxicity.   Disease relevant in vivo models to evaluate drug candidate efficacy in all major therapeutic areas (emphasizing anti-infectives, inflammation, CNS/pain and oncology) and early PK and toxicity assessment.
ADME - Toxicity   Custom Services  
Early pharmacokinetic and safety assessment through a combination of in vitro assays and small animal studies   Customized protein production, cell line and assay development using a diverse set of platforms and technologies   Instant access to reports and analytic data 
Updated by: UET2
Last updated: 23 June 2015